Mikron WP

News

Fulgent Genetics acquires therapeutics development company Fulgent Pharma

Fulgent Genetics intends to transform into a completely integrated precision medicine firm from a genomic diagnostic business.

Comment

Cloud robotics labs are accelerating drug discovery and development

Comment

UK health data collaboration paves the way to study long Covid symptoms

Comment

Companion Diagnostics (CDx): Regulatory trends

Comment

Companion Diagnostics: Technology trends

News

GSK’s top scientist to quit, become CEO of anti-ageing start-up

Features

Approach to spur testosterone production instead of synthesis on the horizon

Comment

Direct-to-Consumer Genetic Tests: Regulatory Trends

Comment

Direct-to-Consumer Genetic Tests: Testing Trends

GlobalData Thematic Intelligence

Features

Will Merck’s Covid-19 pill be available to lower-income countries?

News

Contraceptive mini pill to be made available over the counter in the UK

Features

Academic-industry collaboration: how can licensing and partnerships be made smoother?

Features

Collaboration not competition: is big pharma and big tech a recipe for success?

News

Novartis’s SMA gene therapy Zolgensma to be available for NHS use

Features

Skinny labelling of generics: the beginning of the end for this practice?

Features

Breaking the blood brain barrier: neurology’s greatest challenge

Features

Modelling the human body: a game changer for drug testing?

Features

Are we nearing the end of animal testing in pharma?

Comment

Over-the-counter availability will boost Viagra sales

Features

Brain boosters: exploring the grey area of off-label ‘smart drugs’

News

Cancer Research UK, CPF and NCI partner to develop tests to analyse RAS inhibitors

Features

Inhalable insulin: a losing battle?

Pfizer anti-stroke drug apixaban now available on UK NHS